cyclosporine drops Restasis
Selected indexed studies
- Vernal Keratoconjunctivitis: A Systematic Review. (Clin Rev Allergy Immunol, 2023) [PMID:37658939]
- EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. (Ann Rheum Dis, 2020) [PMID:31672775]
- S2k guideline: Rosacea. (J Dtsch Dermatol Ges, 2022) [PMID:35929658]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Quintessence of currently approved and upcoming treatments for dry eye disease. (2025) pubmed
- S2k guideline: Rosacea. (2022) pubmed
- EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. (2020) pubmed
- Vernal Keratoconjunctivitis: A Systematic Review. (2023) pubmed
- Topical corticosteroids for dry eye. (2022) pubmed
- Topical cyclosporine A therapy for dry eye syndrome. (2019) pubmed
- Water-Free Cyclosporine Ophthalmic Solution vs Vehicle for Dry Eye Disease: A Randomized Clinical Trial. (2024) pubmed
- Plasminogen deficiency. (2017) pubmed
- Eye-Drop Nano-Formulation of Catalase Self-Assembled with Thiolated Chitosan for Effective Treatment of Dry Eye Disease. (2025) pubmed
- Impact of Topical 0.05% Cyclosporine A Eye Drops on Post-Femtosecond-Assisted Laser In Situ Keratomileusis Ocular Surface Recovery: A Randomized Clinical Trial. (2024) pubmed